Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Christine Bestvina   and   Septimiu Murgu.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.238
         
        
        
     
 
    
        
        - 
            A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. J Thorac Oncol. 2022 01; 17(1):130-140.
            
            
                Score: 0.187
            
         
        
        - 
            Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. Nat Cancer. 2022 12; 3(12):1498-1512.
            
            
                Score: 0.051